Iniciar sesión

Skeletal muscle relaxants can target the central nervous system [CNS]to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.

Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs, such as baclofen, diazepam, and tizanidine, primarily act on the CNS. Most of these drugs are administered orally, although some may be given intramuscularly or intravenously. The duration of action of these drugs typically ranges from 5 to 24 hours. Spasmolytic drugs are commonly used to manage severe and chronic spasms caused by conditions such as multiple sclerosis, cerebral palsy, stroke, spinal cord injuries, and muscle injuries. However, they may have side effects such as sedation, weakness, hypotension, and the potential for rebound spasticity upon discontinuing the medication. Antispasmodics have a shorter duration of action, typically lasting from 4 to 6 hours. They can produce strong antimuscarinic effects such as constipation, bradycardia, and urinary retention. An example of an antispasmodic drug is cyclobenzaprine, which is primarily given orally to treat acute spasms resulting from muscle injuries.

Peripherally acting drugs are also classified into neuromuscular blockers and directly acting agents. Succinylcholine, d-tubocurarine, cisatracurium, and rocuronium are some examples of neuromuscular blockers. These drugs are often administered intravenously. Their duration of action ranges from 5 to 60 minutes. These are given along with anesthetics to prolong muscle relaxation during surgeries. They can cause side effects like hypotension, prolonged apnea, intraocular pressure, and postoperative muscle pain. Dantrolene and botulinum toxin are examples of directly acting relaxants that are administered intramuscularly or orally. Duration of action ranges from 4 hours to 2 months. These medications weaken muscle contraction, leading to flaccid paralysis, and effectively treat spasms caused by conditions such as cerebral palsy, multiple sclerosis, and overactive bladder

Tags

Muscle RelaxantsCentrally ActingPeripherally ActingSpasmolytic DrugsAntispasmodic DrugsNeuromuscular BlockersMuscle Tension ReductionBaclofenDiazepamTizanidineCyclobenzaprineSuccinylcholineDantroleneBotulinum ToxinSide EffectsDuration Of Action

Del capítulo 7:

article

Now Playing

7.12 : Peripherally and Centrally Acting Muscle Relaxants: A Comparison

Skeletal Muscle Relaxants

2.9K Vistas

article

7.1 : Unión neuromuscular y bloqueo

Skeletal Muscle Relaxants

2.6K Vistas

article

7.2 : Clasificación de los relajantes del músculo esquelético

Skeletal Muscle Relaxants

2.3K Vistas

article

7.3 : Bloqueadores neuromusculares no despolarizantes (competitivos): mecanismo de acción

Skeletal Muscle Relaxants

1.2K Vistas

article

7.4 : Bloqueadores neuromusculares no despolarizantes (competitivos): acciones farmacológicas

Skeletal Muscle Relaxants

342 Vistas

article

7.5 : Bloqueadores neuromusculares no despolarizantes (competitivos): farmacocinética

Skeletal Muscle Relaxants

404 Vistas

article

7.6 : Bloqueadores despolarizantes: mecanismo de acción

Skeletal Muscle Relaxants

1.0K Vistas

article

7.7 : Bloqueadores despolarizantes: farmacocinéticos

Skeletal Muscle Relaxants

277 Vistas

article

7.8 : Relajantes musculares de acción directa: Dantroleno y toxina botulínica

Skeletal Muscle Relaxants

596 Vistas

article

7.9 : Relajantes del músculo esquelético: efectos adversos

Skeletal Muscle Relaxants

306 Vistas

article

7.10 : Relajantes del músculo esquelético: usos terapéuticos

Skeletal Muscle Relaxants

432 Vistas

article

7.11 : Agentes espasmolíticos: clasificación química

Skeletal Muscle Relaxants

828 Vistas

article

7.13 : Relajantes musculares de acción central: usos terapéuticos

Skeletal Muscle Relaxants

558 Vistas

JoVE Logo

Privacidad

Condiciones de uso

Políticas

Investigación

Educación

ACERCA DE JoVE

Copyright © 2025 MyJoVE Corporation. Todos los derechos reservados